These findings provide novel insights for Alzheimer's disease treatment, suggesting that GCK may serve as an effective therapeutic agent to improve cognitive function through dual mechanisms of suppressing neuroinflammation and protecting neurons. Here, GCK is linked to early-onset autosomal dominant Alzheimer disease.